Clinical trials
Completed Non-Muscle Invasive Bladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UroGen Pharma Ltd. | 3 |
| Halozyme Therapeutics | 2 |
| Protara Therapeutics | 2 |
| Aadi Bioscience, Inc. | 1 |
| Anchiano Therapeutics Israel Ltd. | 1 |
| Asieris Pharmaceutical Technologies Co., Ltd. | 1 |
| CG Oncology, Inc. | 1 |
| Corewell Health West | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Eugene Lee, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 30 |
| Urinary Bladder Neoplasms | 18 |
| Carcinoma in Situ | 4 |
| Carcinoma, Transitional Cell | 4 |
| Urogenital Neoplasms | 2 |
| Urologic Neoplasms | 2 |
| Heartburn | 1 |
| Neoplasms | 1 |
| Photosensitivity Disorders | 1 |
| Urinary Bladder Diseases | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.